Sorensen K N, Sobel R A, Clemons K V, Calderon L, Howell K J, Irani P R, Pappagianis D, Williams P L, Stevens D A
Division of Infectious Diseases, Department of Medicine, Santa Clara Valley Medical Center, San Jose, California 95128, USA.
Antimicrob Agents Chemother. 2000 Nov;44(11):3087-91. doi: 10.1128/AAC.44.11.3087-3091.2000.
A rabbit model of coccidioidal meningitis was used to compare the therapeutic efficacies of terbinafine (TBF) and fluconazole (FCZ). Hydrocortisone acetate-treated New Zealand White male rabbits were infected intracisternally with either 2.2 x 10(4) or 6.4 x 10(4) Coccidioides immitis arthroconidia. Oral treatment with polyethylene glycol 200 (PEG) twice daily (n = 8), TBF twice daily (n = 9; 200 mg/kg of body weight/day), or FCZ once daily (n = 8; 80 mg/kg/day) began on day 5 and continued for 21 days. Mean survival times were 20, 24, and 32 days for rabbits treated with PEG, TBF, and FCZ, respectively. All of the FCZ-treated animals (100%; P = 0.003), 56% of the TBF-treated animals (P = 0.4), and 25% of the PEG-treated animals survived the length of the study. Both FCZ and TBF were effective at reducing the incidence of paresis. Only FCZ was effective at reducing most neurological and systemic signs. FCZ treatments resulted in lower cerebrospinal fluid (CSF) protein concentrations and leukocyte counts and faster clearing of CSF fungal cultures compared with those for PEG-treated controls, but TBF treatments had no significant effect on these parameters. Neither drug affected CSF glucose levels. Mean serum TBF levels by bioassay were within the range of 3.5 to 6.2 microgram/ml at 1, 2, and 4 h postdosing and 0.35 to 7.0 microgram/ml at 14 h postdosing. No TBF was detected in CSF. Mean FCZ levels (24 to 25.5 h postdosing) by bioassay were 16.4 to 19.2 and 13.5 to 19.2 microgram/ml in serum and CSF, respectively. The reduction in the numbers of CFU in the spinal cord and brain was over 100-fold (P = 0.0005) in FCZ-treated animals and 2-fold (P </= 0.2) in TBF-treated animals compared with those in PEG-treated animals. Histopathologic severity (semiquantitative scoring system) was significantly attenuated by FCZ treatment (P = 0. 05) and was slightly attenuated by TBF treatment compared with that for the controls. In conclusion, TBF appeared to have a slight effect on survival, histology, and reduction of the numbers of CFU in tissue; however, these effects were not significant. FCZ was effective at controlling coccidioidal meningitis.
采用球孢子菌性脑膜炎兔模型比较特比萘芬(TBF)和氟康唑(FCZ)的治疗效果。用醋酸氢化可的松处理的新西兰雄性白兔经脑池内接种2.2×10⁴或6.4×10⁴个粗球孢子菌关节孢子。于第5天开始每日两次口服聚乙二醇200(PEG)(n = 8)、每日两次口服TBF(n = 9;200mg/kg体重/天)或每日一次口服FCZ(n = 8;80mg/kg/天),持续21天。接受PEG、TBF和FCZ治疗的兔子平均生存时间分别为20天、24天和32天。所有接受FCZ治疗的动物(100%;P = 0.003)、56%接受TBF治疗的动物(P = 0.4)和25%接受PEG治疗的动物存活至研究结束。FCZ和TBF均能有效降低轻瘫的发生率。只有FCZ能有效减轻大多数神经和全身症状。与PEG治疗的对照组相比,FCZ治疗可使脑脊液(CSF)蛋白浓度和白细胞计数降低,CSF真菌培养物清除更快,但TBF治疗对这些参数无显著影响。两种药物均不影响CSF葡萄糖水平。生物测定法测得给药后1、2和4小时血清TBF平均水平在3.5至6.2μg/ml范围内,给药后14小时为0.35至7.0μg/ml。CSF中未检测到TBF。生物测定法测得给药后24至25.5小时血清和CSF中FCZ平均水平分别为16.4至19.2μg/ml和13.5至19.2μg/ml。与PEG治疗的动物相比,FCZ治疗的动物脊髓和脑中的菌落形成单位(CFU)数量减少超过100倍(P = 0.0005),TBF治疗的动物减少2倍(P≤0.2)。与对照组相比,FCZ治疗显著减轻了组织病理学严重程度(半定量评分系统)(P = 0.05),TBF治疗使其略有减轻。总之,TBF似乎对生存、组织学及组织中CFU数量的减少有轻微影响;然而,这些影响并不显著。FCZ能有效控制球孢子菌性脑膜炎。